Cargando…

Leveraging molecular quantitative trait loci to understand the genetic architecture of diseases and complex traits

There is increasing evidence that many GWAS risk loci are molecular QTL (eQTL, hQTL, sQTL, and/or meQTL). Here, we introduce a new set of functional annotations based on causal posterior probabilities of fine-mapped molecular cis-QTL, using data from the GTEx and BLUEPRINT consortia. We show that th...

Descripción completa

Detalles Bibliográficos
Autores principales: Hormozdiari, Farhad, Gazal, Steven, van de Geijn, Bryce, Finucane, Hilary, Ju, Chelsea J.-T., Loh, Po-Ru, Schoech, Armin, Reshef, Yakir, Liu, Xuanyao, O’Connor, Luke, Gusev, Alexander, Eskin, Eleazar, Price, Alkes L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6030458/
https://www.ncbi.nlm.nih.gov/pubmed/29942083
http://dx.doi.org/10.1038/s41588-018-0148-2
_version_ 1783337151913525248
author Hormozdiari, Farhad
Gazal, Steven
van de Geijn, Bryce
Finucane, Hilary
Ju, Chelsea J.-T.
Loh, Po-Ru
Schoech, Armin
Reshef, Yakir
Liu, Xuanyao
O’Connor, Luke
Gusev, Alexander
Eskin, Eleazar
Price, Alkes L.
author_facet Hormozdiari, Farhad
Gazal, Steven
van de Geijn, Bryce
Finucane, Hilary
Ju, Chelsea J.-T.
Loh, Po-Ru
Schoech, Armin
Reshef, Yakir
Liu, Xuanyao
O’Connor, Luke
Gusev, Alexander
Eskin, Eleazar
Price, Alkes L.
author_sort Hormozdiari, Farhad
collection PubMed
description There is increasing evidence that many GWAS risk loci are molecular QTL (eQTL, hQTL, sQTL, and/or meQTL). Here, we introduce a new set of functional annotations based on causal posterior probabilities of fine-mapped molecular cis-QTL, using data from the GTEx and BLUEPRINT consortia. We show that these annotations are far more strongly enriched for heritability (e.g. 5.84x for eQTL; P=1.19×10(−31)) across 41 independent diseases and complex traits than annotations containing all significant molecular QTL (1.80x for eQTL). eQTL annotations that were obtained by meta-analyzing all GTEx tissues generally performed best, but tissue-specific eQTL annotations produced stronger enrichments for blood- and brain-related diseases and traits. Notably, eQTL annotations restricted to loss-of-function intolerant genes from ExAC were even more strongly enriched for heritability (17.06x; P=1.20×10(−35)). All molecular QTL except sQTL remained significantly enriched in a joint analysis, implying that each of these annotations is uniquely informative for disease and complex trait architectures.
format Online
Article
Text
id pubmed-6030458
institution National Center for Biotechnology Information
language English
publishDate 2018
record_format MEDLINE/PubMed
spelling pubmed-60304582018-12-25 Leveraging molecular quantitative trait loci to understand the genetic architecture of diseases and complex traits Hormozdiari, Farhad Gazal, Steven van de Geijn, Bryce Finucane, Hilary Ju, Chelsea J.-T. Loh, Po-Ru Schoech, Armin Reshef, Yakir Liu, Xuanyao O’Connor, Luke Gusev, Alexander Eskin, Eleazar Price, Alkes L. Nat Genet Article There is increasing evidence that many GWAS risk loci are molecular QTL (eQTL, hQTL, sQTL, and/or meQTL). Here, we introduce a new set of functional annotations based on causal posterior probabilities of fine-mapped molecular cis-QTL, using data from the GTEx and BLUEPRINT consortia. We show that these annotations are far more strongly enriched for heritability (e.g. 5.84x for eQTL; P=1.19×10(−31)) across 41 independent diseases and complex traits than annotations containing all significant molecular QTL (1.80x for eQTL). eQTL annotations that were obtained by meta-analyzing all GTEx tissues generally performed best, but tissue-specific eQTL annotations produced stronger enrichments for blood- and brain-related diseases and traits. Notably, eQTL annotations restricted to loss-of-function intolerant genes from ExAC were even more strongly enriched for heritability (17.06x; P=1.20×10(−35)). All molecular QTL except sQTL remained significantly enriched in a joint analysis, implying that each of these annotations is uniquely informative for disease and complex trait architectures. 2018-06-25 2018-07 /pmc/articles/PMC6030458/ /pubmed/29942083 http://dx.doi.org/10.1038/s41588-018-0148-2 Text en Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use: http://www.nature.com/authors/editorial_policies/license.html#terms
spellingShingle Article
Hormozdiari, Farhad
Gazal, Steven
van de Geijn, Bryce
Finucane, Hilary
Ju, Chelsea J.-T.
Loh, Po-Ru
Schoech, Armin
Reshef, Yakir
Liu, Xuanyao
O’Connor, Luke
Gusev, Alexander
Eskin, Eleazar
Price, Alkes L.
Leveraging molecular quantitative trait loci to understand the genetic architecture of diseases and complex traits
title Leveraging molecular quantitative trait loci to understand the genetic architecture of diseases and complex traits
title_full Leveraging molecular quantitative trait loci to understand the genetic architecture of diseases and complex traits
title_fullStr Leveraging molecular quantitative trait loci to understand the genetic architecture of diseases and complex traits
title_full_unstemmed Leveraging molecular quantitative trait loci to understand the genetic architecture of diseases and complex traits
title_short Leveraging molecular quantitative trait loci to understand the genetic architecture of diseases and complex traits
title_sort leveraging molecular quantitative trait loci to understand the genetic architecture of diseases and complex traits
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6030458/
https://www.ncbi.nlm.nih.gov/pubmed/29942083
http://dx.doi.org/10.1038/s41588-018-0148-2
work_keys_str_mv AT hormozdiarifarhad leveragingmolecularquantitativetraitlocitounderstandthegeneticarchitectureofdiseasesandcomplextraits
AT gazalsteven leveragingmolecularquantitativetraitlocitounderstandthegeneticarchitectureofdiseasesandcomplextraits
AT vandegeijnbryce leveragingmolecularquantitativetraitlocitounderstandthegeneticarchitectureofdiseasesandcomplextraits
AT finucanehilary leveragingmolecularquantitativetraitlocitounderstandthegeneticarchitectureofdiseasesandcomplextraits
AT juchelseajt leveragingmolecularquantitativetraitlocitounderstandthegeneticarchitectureofdiseasesandcomplextraits
AT lohporu leveragingmolecularquantitativetraitlocitounderstandthegeneticarchitectureofdiseasesandcomplextraits
AT schoecharmin leveragingmolecularquantitativetraitlocitounderstandthegeneticarchitectureofdiseasesandcomplextraits
AT reshefyakir leveragingmolecularquantitativetraitlocitounderstandthegeneticarchitectureofdiseasesandcomplextraits
AT liuxuanyao leveragingmolecularquantitativetraitlocitounderstandthegeneticarchitectureofdiseasesandcomplextraits
AT oconnorluke leveragingmolecularquantitativetraitlocitounderstandthegeneticarchitectureofdiseasesandcomplextraits
AT gusevalexander leveragingmolecularquantitativetraitlocitounderstandthegeneticarchitectureofdiseasesandcomplextraits
AT eskineleazar leveragingmolecularquantitativetraitlocitounderstandthegeneticarchitectureofdiseasesandcomplextraits
AT pricealkesl leveragingmolecularquantitativetraitlocitounderstandthegeneticarchitectureofdiseasesandcomplextraits